A Study of TAK-625 for the Treatment of Alagille Syndrome (ALGS)

NCT05543174 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda